ACCESS Cohort Studies

uMed's ACCESS Cohort Studies

Combining real-world evidence with the power of patient-generated data

Using uMed’s cutting edge ACCESS Research Platform and master protocols embedded across a global network of healthcare institutions, ACCESS Cohort Studies address specific evidence gaps by allowing teams to build datasets that utilise technology to combine the power of clinical and patient generated data.

View our live Cohorts

Research that’s accessible to everyone

For Patients

Participation from home removes the physical, cost & time burden of travelling to a site
Offers research opportunities that may otherwise be inaccessible
Provided with insights and feedback on the impact of their participation
Patient Services team available to support their participation

Find out more

For Healthcare Providers

Support better access to research for your patients
No additional workload for your or your practice staff
uMed’s support team alleviates any pressure of calls to your practice regarding study participation
Generate ongoing revenue to support your practice

Find out more

For Life Science Researchers

Access well characterized consented patient cohorts
Reach untapped patient populations
Answer new research questions at speed, without setting up from scratch
Build credible clinical evidence from ethics committee/IRB approved protocol programmes
Access exclusive real-time integrated clinical and patient outcome data

Find out more

Build a complete picture from comprehensive, regulatory approved data

Access live cohorts of consented patients that can be continuously engaged to collect specific endpoints

EMR data

Routinely collected from integration with our network of healthcare providers

Patient generated data

Remotely collected directly from patients via ePROS, validated surveys and questionnaires & wearables

Clinical data

Objectively measurable parameters, clinician diagnoses, & objective movement data

Run a Study

Rapidly build evidence across the study lifecycle

Master protocol underpinned by uMed’s ACCESS Research Platform provides answers to multiple clinical questions through decentralised sub-studies.

Pre Clinical

Natural History Study

Capture data points which explain the progress of disease including data points not captured in your clinical trial or which are easily obtainable from EMR data or secondary literature

Phase I - III Trials

Patient preference studies

Clinical trial design decisions and pre-screen patients for interventional trials

Phase I - III Trials

External control arms

Match outcome measures from interventional arms

Market Access

HEOR insights

Generate evidence beyond phase 3 to support market access goals

Market Access

Comparative effectiveness studies

Build evidence post-market to drive access and adoption

Lifecycle Management

Long term safety data

Collect long-term outcomes to comply with regulator defined safety reporting

Patient perspectives

It's been 5 years since my diagnosis but this is my first time taking part in Parkinson's research because of my poor mobility. Being able to take part despite having no internet is a big positive and your nurses make this possible.

Carole Henrickson, 75, Hull

AccessPD Participant

uMed's ACCESS Cohort Studies

Research that’s accessible to everyone

For Patients

For Healthcare Providers

For Life Science Researchers

Build a complete picture from comprehensive, regulatory approved data

Answers key research questions with rapid access to custom data & insights

Clinical & Patient Insight Generation

Rapidly build evidence across the study lifecycle

Patient perspectives

Live ACCESS Cohort Studies